作为结肠腺癌中的预后和治疗标,KCNJ11
1Department of Laboratory, Li Huili Hospital, Ningbo Medical Center, Ningbo, China.
Translational cancer research
|October 29, 2025
概括
在结肠腺癌 (COAD) 中,KCNJ11被上调,与生存率差和免疫透改变有关. 该基因显示出诊断潜力,并与治疗敏感性相关,这表明KCNJ11是COAD的生物标志物.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 分子生物学分子生物学
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康问题.
- 目前尚不清楚KCNJ11在结肠腺癌 (COAD) 中的作用.
- 本研究使用生物信息学研究KCNJ11在COAD中的功能.
研究的目的:
- 分析KCNJ11在COAD中的表达.
- 评估KCNJ11的诊断和预后价值.
- 探索KCNJ11与免疫透和治疗敏感性的关联.
主要方法:
- 使用TCGA和GTEx数据集进行KCNJ11表达式分析.
- 使用Kaplan-Meier和ROC曲线进行生存和诊断评估.
- 进行了途径分析 (GO,KEGG,GSEA) 和评估了免疫透 (CIBERSORT).
主要成果:
- 在COAD组织中,KCNJ11被显著上调,与总体存活率降低相关.
- 观察到高的诊断准确度 (AUC为0.866-0.877). 这是一个很好的结果.
- 增加的KCNJ11表达与增加的巨细胞透和改变的免疫检查点标记物表达相关 (PD-L1, TIM-3, CTLA-4).
结论:
- KCNJ11作为COAD诊断和预后的潜在生物标志物.
- KCNJ11与免疫透的关联表明它在瘤微环境中的作用.
- 在COAD中,KCNJ11可能是新的治疗策略的目标.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K